On October 15, 2025, China’s National Medical Products Administration (NMPA) announced the cancellation of 80 drug registration certificates, including well-known products such as loratadine tablets.

The resurgence of COVID-19 in China has presented challenges to our mental health under lockdown and made grit more important than ever to help us get through difficult times.

Each year since 1950, people around the world have marked April 7 as World Health Day.

April 26, 2026. Shanghai – artificial intelligence is accelerating and establishing a presence in the centre of the healthcare industry. From drug discovery and R&D to hospital management, clinical assistance, patient services, and health management, AI is rapidly reshaping the industry chain and value creation methods. Driven by technological evolution, market demand, and industrial upgrading, the question of how to leverage AI at all stages of development, from concept to implementation and from single-point testing to large-scale application, has become an important topic of common concern in the industry.

As artificial intelligence and robotics redefine the future of healthcare, CEIBS today welcomed Chairman and CEO of Medtronic Geoff Martha to the school’s Shanghai campus for a keynote address at the latest CEIBS Executive Forum.

Prof. Eric Bouteiller quoted in Les Echoes story on China's emergence as a leader in the pharmaceutical sector.

Join us for a CEIBS Executive Forum on March 24, 2026, with Mr. Geoff Martha, Chairman and CEO of Medtronic, who will give a keynote speech on the theme of Engineering the Extraordinary: Leading Through the Next Wave of MedTech Innovation.

Join us in Paris on June 1 for an exclusive talk with CEIBS Professor Eric Bouteiller on the Latest Trends in China’s Pharmaceutical and Healthcare Market.

Please join us on November 3, 2022 for this offline Master Class with CEIBS Professor Eric Bouteiller on The Challenges of The Healthcare Industries in China.